Skip to main content
Trials logoLink to Trials
. 2019 Jun 20;20:368. doi: 10.1186/s13063-019-3519-9

Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial

Thomas G de Leeuw 1,, Laura Mangiarini 2, Rebecca Lundin 3, Florentia Kaguelidou 4,5,6, Tjitske van der Zanden 7, Oscar Della Pasqua 8, Dick Tibboel 7, Adriana Ceci 2, Saskia N de Wildt 7,9; on behalf of the GAPP consortium
PMCID: PMC6585026  PMID: 31221222

Correction to: Trials (2019) 20:49.

https://doi.org/10.1186/s13063-018-3169-3

Following publication of the original article [1], we have been notified that the tagging of one of the author names was done incorrectly in the XML version of the paper. Original and corrected tagging can be seen below.

  • Incorrect name tagging:

    Last Name: Pasqua.

    First Name: Oscar Della.

  • Correct author name tagging:

    Last Name: Della Pasqua.

    First Name: Oscar.

Reference

  • 1.Leeuw, et al. Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial. Trials. 2019;20:49. doi: 10.1186/s13063-018-3169-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Trials are provided here courtesy of BMC

RESOURCES